UPL bags 'Best Patent Portfolio Award in the CII - Industrial IP Awards 2020'
UPL has won the award in the category of Best Patent Portfolio, Large (Lifesciences/Pharma) for its pioneering Intellectual property (IP) research and innovation
UPL has won the award in the category of Best Patent Portfolio, Large (Lifesciences/Pharma) for its pioneering Intellectual property (IP) research and innovation
The company is expecting tremendous growth and a better quarterly performance
The acquisition is by way of subscription to the issue of 492,630 equity shares of SSPL
The present installed capacity of the Caustic Soda plant is 500 TPD and the company has commissioned 100 TPD expansion plants in the month of August 2019.
ICICI Direct Research expects chemical universe to register topline growth of 10.6% YoY while bottomline is expected to grow 15.3% YoY in the last quarter.
Groundbreaking of the second plant expected in September 2021
By creating this platform, Solvay is increasing its resources dedicated to this emerging market, including efforts in research and innovation
The business unit will manufacture and supply a broad, global portfolio of pavement-marking products, including paint, thermoplastics and other advanced technologies, to customers in government, military, contracting, commercial infrastructure, engineering and architecture
Company has unveiled Electrolight as its global automotive color of the year for 2021
Viruses evolve into new strains when there is a change to their genetic composition.
The new IFF will lead the evolution of the global value chain for consumer goods and commercial products with unmatched scale, R&D capabilities and portfolio strength.
The proposed combination envisages acquisition of stake in Ecom Express Private Limited by PG Esmeralda Pte. Limited (PG Esmeralda).
Lasa Supergenerics Limited has received WHO GMP Certificate for its manufacturing facility situated at Khed in Ratnagiri.
The Phase 2 study of Sputnik V was conducted on 100 subjects as part of the randomized, double-blind, parallel-group, placebo-controlled study in India.
The total scope of the investment is intended to support approximately 20 kilotons of LCP production per year with the first phase of the project expected to come on-line in 2024.
This transaction is consistent with Azelis’ corporate strategy of complementing organic growth with strategic acquisitions.
LANXESS will significantly expand its range of products for the growth market animal hygiene
The closing of the transaction, consistent with Azelis’ corporate strategy of complementing organic growth with strategic acquisitions, is expected in the next three months.
The event had no significant impact on other production facilities.
The plant has been temporarily shut-down for maintenance work from today, 11th January 2021.
Subscribe to our newsletter & stay updated.